NCT02577718View on ClinicalTrials.gov

Safety and Effectiveness of Novel Nitroglycerin Based Catheter Lock Solution

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

November 30, 2015

Primary Completion Date

June 22, 2016

Study Completion Date

October 31, 2016

Conditions
Catheter-Associated InfectionsCatheter-Related Infections
Interventions
DRUG

Nitroglycerin-citrate-ethanol (NiCE)

Lock solution instilled in catheter lumens for 2 hours then flushed. Administration for up to 30 days, daily as in-patient or once weekly as out-patient

Trial Locations (1)

77030

MD Anderson Cancer Center, Houston

All Listed Sponsors
collaborator

M.D. Anderson Cancer Center

OTHER

lead

Novel Anti-Infective Technologies, LLC

INDUSTRY

NCT02577718 - Safety and Effectiveness of Novel Nitroglycerin Based Catheter Lock Solution | Biotech Hunter | Biotech Hunter